We are live on ! Find out more
DFTX

Definium Therapeutics
DFTX

155 hedge funds and large institutions have $14.9M invested in Definium Therapeutics in 2022 Q2 according to their latest regulatory filings, with 49 funds opening new positions, 26 increasing their positions, 41 reducing their positions, and 51 closing their positions.

New
Increased
Maintained
Reduced
Closed

119% more call options, than puts

Call options by funds: $1.84M | Put options by funds: $842K

0% more funds holding in top 10

Funds holding in top 10: 1 → 1 (0)

0.4% less ownership

Funds ownership: 0.76% → 0.36% (-0.4%)

4% less first-time investments, than exits

New positions opened: 49 | Existing positions closed: 51

3% less funds holding

Funds holding: 159 → 155 (-4)

37% less repeat investments, than reductions

Existing positions increased: 26 | Existing positions reduced: 41

72% less capital invested

Capital invested by funds: $53.6M → $14.9M (-$38.6M)

Holders
155
Holders Change
-4
Holders Change %
-2.52%
% of All Funds
2.61%
Holding in Top 10
1
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
0.02%
New
49
Increased
26
Reduced
41
Closed
51
Calls
$1.84M
Puts
$842K
Net Calls
+$1M
Net Calls Change
-$1.77M

Top Buyers

Rank Fund Capital Flow
1
Millennium Management
Millennium Management
New York
+$3.91M
2
E
Ergoteles
New York
+$917K
3
LPL Financial
LPL Financial
California
+$653K
4
Citadel Advisors
Citadel Advisors
Florida
+$457K
5
MFG
Merit Financial Group
Georgia
+$449K

Top Sellers

Rank Fund Capital Flow
1
BlackRock
BlackRock
New York
-$13.7M
2
State Street
State Street
Massachusetts
-$4.37M
3
Northern Trust
Northern Trust
Illinois
-$2.52M
4
Geode Capital Management
Geode Capital Management
Massachusetts
-$2.21M
5
Vanguard Group
Vanguard Group
Pennsylvania
-$1.41M
Name Holding Trade Value Shares
Change 		Change in
Stake
Simplex Trading
101
Simplex Trading
Illinois
$7K +$9.31K +736 New
FNT
102
First National Trust
Pennsylvania
$6K – – –
EDRH
103
Edmond de Rothschild Holding
Switzerland
$6K +$8.44K +667 New
IAS
104
Investment Advisory Services
Texas
$6K +$8.44K +667 New
BZWA
105
Blue Zone Wealth Advisors
California
$6K +$8.54K +675 New
TWC
106
TD Waterhouse Canada
Ontario, Canada
$5.2K -$2.02K -160 -24%
TIM
107
Tortoise Investment Management
New York
$4K – – –
AFG
108
Albion Financial Group
Utah
$3K – – –
GWS
109
Glassman Wealth Services
Virginia
$3K +$4.21K +333 New
New York State Common Retirement Fund
110
New York State Common Retirement Fund
New York
$2K -$172K -13,567 -99%
Citigroup
111
Citigroup
New York
$2K -$9.77K -772 -76%
KTC
112
Kistler-Tiffany Companies
Pennsylvania
$2K – – –
JP Morgan Chase
113
JP Morgan Chase
New York
$1K -$127K -10,070 -100%
AF
114
Allworth Financial
California
$1K – – –
ARMC
115
American Research & Management Company
Massachusetts
$1K – – –
AF
116
Arrow Financial
New York
$1K – – –
BAM
117
Baldrige Asset Management
Pennsylvania
$1K – – –
BC
118
Burleson & Co
California
$1K – – –
FRA
119
Front Row Advisors
California
$1K – – –
Rockefeller Capital Management
120
Rockefeller Capital Management
New York
$1K – – –
TCM
121
Tradewinds Capital Management
Washington
$1K – – –
US Bancorp
122
US Bancorp
Minnesota
$1K – – –
HWM
123
HighMark Wealth Management
Minnesota
$1K +$139 +11 +8%
Northwestern Mutual Wealth Management
124
Northwestern Mutual Wealth Management
Wisconsin
$1K +$784 +62 New
CWA
125
Clearview Wealth Advisors
Oregon
$1K +$848 +67 New
3 4
5
6 7

DFTX Hedge Fund Activity: Q2 2022 in Review

155 of the 5,936 institutional investors tracked by Wall St. Rank reported a position in Definium Therapeutics (DFTX) for Q2 2022, worth a combined $14.9M — down 72% from $53.6M a quarter earlier.

Sellers outnumbered buyers: 51 funds closed out of DFTX and 49 opened new positions — a net loss of 2 holders — while 41 trimmed existing stakes and 26 added.

The largest buyer was Millennium Management, adding an estimated $3.91M. The largest seller was BlackRock, cutting an estimated $13.7M.

  • 155 institutional investors held Definium Therapeutics (DFTX) as of Q2 2022, down from 159 in Q1 2022.
  • Funds reported $14.9M of Definium Therapeutics stock for Q2 2022, down 72% quarter-over-quarter.
  • 49 funds opened new Definium Therapeutics positions in Q2 2022 and 51 closed out, a net change of -2 holders.
  • The largest Definium Therapeutics buyer in Q2 2022 was Millennium Management, an estimated $3.91M added.
  • The largest Definium Therapeutics seller in Q2 2022 was BlackRock, an estimated $13.7M sold.

Based on aggregated 13F filings for Q2 2022.